An online decision aid for patients with metastatic melanoma: results of the randomized controlled trial "PEF-Immun"

Background: Treatment decisions in metastatic melanoma (MM) are highly dependent on patient preferences and require the patients’ involvement. The complexity of treatment options with their individual advantages and disadvantages is often overwhelming. We therefore developed an online patient decisi...

Full description

Saved in:
Bibliographic Details
Main Authors: Grabbe, Pia (Author) , Borchers, Milena (Author) , Gschwendtner, Kathrin M. (Author) , Strobel, Sophia (Author) , Wild, Beate (Author) , Kirchner, Marietta (Author) , Kälber, Katharina (Author) , Rendon, Adriana (Author) , Steininger, Julian (Author) , Meier, Friedegund (Author) , Hassel, Jessica C. (Author) , Bieber, Christiane (Author)
Format: Article (Journal)
Language:English
Published: 14 June 2024
In: Deutsches Ärzteblatt
Year: 2024, Volume: 121, Issue: 12, Pages: 385-392
ISSN:1866-0452
DOI:10.3238/arztebl.m2024.0053
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3238/arztebl.m2024.0053
Verlag, kostenfrei, Volltext: https://www.aerzteblatt.de/int/archive/article?id=239793
Get full text
Author Notes:Pia Grabbe, Milena S. Borchers, Kathrin M. Gschwendtner, Sophia Strobel, Beate Wild, Marietta Kirchner, Katharina Kälber, Adriana Rendon, Julian Steininger, Friedegund Meier, Jessica C. Hassel, Christiane Bieber
Description
Summary:Background: Treatment decisions in metastatic melanoma (MM) are highly dependent on patient preferences and require the patients’ involvement. The complexity of treatment options with their individual advantages and disadvantages is often overwhelming. We therefore developed an online patient decision aid (PtDA) to facilitate shared decision making (SDM).
Item Description:Gesehen am 21.07.2025
Physical Description:Online Resource
ISSN:1866-0452
DOI:10.3238/arztebl.m2024.0053